Preventing recurrence of endometriosis by means of long-Acting progestogen therapy (PRE-EMPT): Report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitment

On behalf of the PRE-EMPT trial collaborative group

Institute of Applied Health Sciences
Applied Health Sciences

University of Birmingham
Birmingham City University
Aberdeen Maternity Hospital
University of Edinburgh
University of Oxford
NHS Grampian
University College London Hospitals NHS Foundation Trust
Birmingham Women's and Children's NHS Foundation Trust
University of Cambridge
Leeds Beckett University
The Robert Jones and Agnes Hunt Orthopaedic and District Hospital NHS Trust

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Preventing recurrence of endometriosis by means of long-Acting progestogen therapy (PRE-EMPT): Report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitment'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Preventing recurrence of endometriosis by means of long-Acting progestogen therapy (PRE-EMPT): Report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitment

Fingerprint

Medicine & Life Sciences